From the Mayo Clinic network
Long-term tests in mice indicate that a genetically modified (GM) brand of soybean oil causes less obesity and insulin resistance than conventional soybean oil, but doesn’t lead to lower incidences of diabetes or fatty liver….
A study in BMC Public Health finds that although men’s magazine refer to scientific information, “the content, format and scientific basis of dietary content of MH leaves much to be desired. The dietary advice as provided may not be conducive to public health”.
BMC Public Health. 2014 Oct 11;14:1062. doi: 10.1186/1471-2458-14-1062.
Dietary advice for muscularity, leanness and weight control in Men’s Health magazine: a content analysis.
Cook TM, Russell JM, Barker ME1.
The obesity epidemic is straining resources at health care facilities, as hospitals learn to adapt to heavier patients and the special resources needed to care for them.
“Incremental lifetime costs of a patient with obesity or overweight (vs. normal weight) increased with the patient’s age, peaked at age 50, and decreased with older ages. However, weight reduction even in older adults still yielded incremental cost savings.”
The Childhood Obesity Intervention Cost-Effectiveness Study (CHOICES),a collaboration between the Harvard School of Public Health, Columbia University and research partners at Deakin and Queensland University in Australia, is working to help reverse the US obesity epidemic by identifying the most cost-effective childhood obesity interventions.
“FDA is issuing an update to alert health care providers of five reports of unanticipated deaths that occurred from 2016 to present in patients with liquid-filled intragastric balloon systems used to treat obesity. Four reports involve the Orbera Intragastric Balloon System, manufactured by Apollo Endo Surgery, and one report involves the ReShape Integrated Dual Balloon System, manufactured by ReShape Medical Inc.
All five reports indicate that patient deaths occurred within a month or less of balloon placement…..”
Please read the FDA report of 08/10/2017 HERE
A study from the University of Texas San Antonio and published in the journal Cancer suggests that
“… women younger than age 60 diagnosed with breast cancer who have a genetic risk factor for obesity have a higher risk for gaining weight and therefore should begin a weight-loss program to increase their chance for survival.”
Sadim, M., Xu, Y., Selig, K., Paulus, J., Uthe, R., Agarwl, S., Dubin, I., Oikonomopoulou, P., Zaichenko, L., McCandlish, S. A., Van Horn, L., Mantzoros, C., Ankerst, D. P. and Kaklamani, V. G. (2017), A prospective evaluation of clinical and genetic predictors of weight changes in breast cancer survivors. Cancer, 123: 2413–2421. doi:10.1002/cncr.30628
JAMA Surgery study finds waiting until BMI rises more may lead to less good outcomes:
In depth story of how the focus of losing weight has changed from looking better to feeling better and how Oprah bought a 10 percent stake in Weight Watchers for $43 million.